83 reports

  • STAGE DEFINITIONS FOR COLORECTAL CANCER
  • TREATMENT DURATION IN COLORECTAL CANCER
  • Colorectal Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • Aging Population to Increase Disease Prevalence
  • 9.1.3 INVESTIGATIONAL NEW DRUG/CLINICAL TRIAL AUTHORIZATION-FILED
  • Cancer
  • Colorectal Cancer
  • World
  • Market Size
  • Merck & Co., Inc.
  • 3.1 BIBLIOGRAPHY
  • MM, Five-Year Diagnosed Prevalent Cases of CRC (N), Both Sexes, Ages ≥18 Years,
  • Colorectal Cancer
  • China
  • Germany
  • Forecast
  • Cancer Epidemiology Group

Key Features of the Report: - Colorectal Cancer Patient Flow - Colorectal Cancer Prevalence - Colorectal Cancer Diagnosed Patients - Colorectal Cancer Treated Patients

  • Colorectal Cancer
  • Europe
  • France
  • World
  • Forecast

Colorectal cancer

4546 5000 3864
  • Colorectal cancer Disease Coverage | Pipeline: Colorectal Cancer
  • Colorectal cancer Disease Coverage | Pipeline: Colorectal Cancer
  • Colorectal Cancer
  • Europe
  • Japan
  • World
  • Taiho Pharmaceutical Co., Ltd.
  • Global Colorectal Cancer Drugs Market
  • Global Colorectal Cancer Drugs Market
  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.

Colorectal Cancer Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Colorectal Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Colorectal Cancer pipeline products,

  • Colorectal Cancer
  • France
  • Germany
  • Italy
  • Market Size
  • 5.2 References
  • Introduction
  • Cancer
  • Colorectal Cancer
  • Therapy
  • United States
  • Roche Group

Key Features of the Report: - Colorectal Cancer Patient Flow - Colorectal Cancer Prevalence - Colorectal Cancer Diagnosed Patients - Colorectal Cancer Treated Patients

  • Colorectal Cancer
  • Europe
  • France
  • Germany
  • Forecast
  • TREATMENT OF COLORECTAL CANCER PATIENTS
  • Duke's Staging Of Colorectal Cancer
  • Cancer
  • Colorectal Cancer
  • Pathology
  • Asia
  • Europe

Colorectal Cancer Forecast and Market Analysis to 2036 CONTENTS ## FORECAST: COLORECTAL CANCER IN THE US, JAPAN, AND ##EU ## Executive Summary ## Market Overview and Trends ## Methodology and Market Definition ## Avastin (bevacizumab) ## CPP-##X (eflornithine/ s

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Europe
  • Japan

Colorectal Cancer Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Colorectal Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Colorectal Cancer pipeline products,

  • Colorectal Cancer
  • Europe
  • France
  • Germany
  • Market Size

The World Colorectal Cancer Drugs Market, 2015-2025 ##. ## Global Colorectal Cancer Drugs Market Forecast 2015-2025 ##. ## Geographical Colorectal Cancer Drugs Market Forecasts 2015-2025 ##. ##. ## The US Colorectal Cancer Drugs Market, ##

  • Cancer
  • Colorectal Cancer
  • Pathology
  • World
  • Market Size

Japan Colorectal Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Colorectal Cancer Treatments ##) Colorectal Cancer Pipeline ##) Japan Colorectal Cancer Epidemiol

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Japan
  • Market Size

UK Colorectal Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Colorectal Cancer Treatments ##) Colorectal Cancer Pipeline ##) UK Colorectal Cancer Epidemiology ##)

  • Cancer
  • Colorectal Cancer
  • Pathology
  • United Kingdom
  • Market Size

Germany Colorectal Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Colorectal Cancer Treatments ##) Colorectal Cancer Pipeline ##) Germany Colorectal Cancer Epide

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Germany
  • Market Size

Italy Colorectal Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Colorectal Cancer Treatments ##) Colorectal Cancer Pipeline ##) Italy Colorectal Cancer Epidemiol

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Italy
  • Market Size

France Colorectal Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Colorectal Cancer Treatments ##) Colorectal Cancer Pipeline ##) France Colorectal Cancer Epidemi

  • Cancer
  • Colorectal Cancer
  • Pathology
  • France
  • Market Size

Spain Colorectal Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Colorectal Cancer Treatments ##) Colorectal Cancer Pipeline ##) Spain Colorectal Cancer Epidemiol

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Spain
  • Market Size

US Colorectal Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Colorectal Cancer Treatments ##) Colorectal Cancer Pipeline ##) US Colorectal Cancer Epidemiology ##)

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Market Size
  • Local colorectal cancer symptoms
  • Systemic colorectal cancer symptoms
  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Sanofi S.A.

Welcome to having the world of colorectal cancer at your fingertips with " Target Atlas in Colorectal Cancer: A Competitive Outlook"!

  • Cancer
  • Colorectal Cancer

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics ## Table of Contents ## Table of Contents ## ##. ## List of Tables ## ##. ## List of Figures ## ## Introduction ## ##. ## Colorectal Cancer ##

  • Colorectal Cancer
  • Therapy
  • Japan
  • World
  • Forecast
  • 6.1.3 NATIONAL SCREENING POLICIES FOR COLORECTAL CANCER
  • SHOWS THE ESTIMATED BURDEN OF ESOPHAGEAL, GASTRIC, AND COLORECTAL CANCER IN DEVELOPED AND DEVELOPING REGIONS IN 2012.
  • Colorectal Cancer
  • Arthrex, Inc.
  • Boston Scientific Corporation
  • EndoChoice, Inc.
  • FUJIFILM Holdings Corporation
  • Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Colorectal Cancer
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.
  • Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Colorectal Cancer
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.
  • Colorectal cancer mortality per 100,000 individuals in European countries 2003 and
  • Colorectal cancer mortality per 100,000 individuals in APAC 2003 and 2013
  • Colorectal Cancer
  • Hospital
  • World
  • Beckman Coulter, Inc.
  • Epigenomics AG
  • 11.1 Factors Impacting Market Growth
  • Global colonoscopy devices market segmentation by geography: Growth lifecycle analysis
  • Colorectal Cancer
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Olympus Corporation

Physician Views: Avastin to lose share as front-line therapy for first-line metastatic colorectal cancer?

  • Cancer
  • Colorectal Cancer
  • Pathology
  • United States
  • Market Description
  • Colorectal cancer
  • Executive summary
  • Colorectal Cancer
  • World
  • Forecast
  • DiaSorin S.p.A.
  • Quidel Corporation